US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Core High Dividend ETF

137.07

+1.361.00%

Post-market: 137.490.4200+0.31%19:33 EST

Volume:845.16K

Turnover:115.66M

Market Cap:13.30B

PE:- -

High:137.20

Open:136.03

Low:136.03

Close:135.71

52wk High:137.20

52wk Low:106.01

Shares:97.05M

Float Shares:97.05M

Volume Ratio:0.91

T/O Rate:0.87%

Dividend:3.91

Dividend Rate:2.85%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

ETF & Stock Investment+1.81%

Fractional Shares+1.81%

Capital Flow

Inflow:

Outflow:

News

Libevitug Approved in China as First-in-Class Hepatitis D Treatment

Vir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating

Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®

Vir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HDV"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HDV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HDV\",,,,,undefined,":{"symbol":"HDV","market":"US","secType":"STK","nameCN":"iShares Core High Dividend ETF","latestPrice":137.07,"timestamp":1770411600000,"preClose":135.71,"halted":0,"volume":845157,"hourTrading":{"tag":"盘后","latestPrice":137.49,"preClose":137.07,"latestTime":"19:33 EST","volume":7322,"amount":1003714.2149,"timestamp":1770424431701,"change":0.42,"changeRate":0.003064,"amplitude":0.004249},"delay":0,"changeRate":0.010021369095866076,"floatShares":97050000,"shares":97050000,"eps":0,"marketStatus":"Market Closed","change":1.36,"latestTime":"02-06 16:00:00 EST","open":136.03,"high":137.2,"low":136.03,"amount":115658839.58358,"amplitude":0.008621,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":135.71,"sharesOutstanding":97050000,"nav":135.72514,"aum":13172124837,"dividendRate":0.028518,"bidAskSpread":0.000201,"preHourTrading":{"tag":"盘前","latestPrice":136.1667,"preClose":135.71,"latestTime":"09:25 EST","volume":142,"amount":19298.85222,"timestamp":1770387937711,"change":0.4567,"changeRate":0.003365,"amplitude":0.013116},"postHourTrading":{"tag":"盘后","latestPrice":137.49,"preClose":137.07,"latestTime":"19:33 EST","volume":7322,"amount":1003714.2149,"timestamp":1770424431701,"change":0.42,"changeRate":0.003064,"amplitude":0.004249},"volumeRatio":0.9067150673370639,"impliedVol":0.1182,"impliedVolPercentile":0.6175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HDV\",,,,,undefined,":{"symbol":"HDV","floatShares":97050000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9067150673370639,"shares":97050000,"dividePrice":3.909,"high":137.2,"amplitude":0.008621,"preClose":135.71,"low":136.03,"week52Low":106.005,"pbRate":"--","week52High":137.2,"institutionHeld":0,"latestPrice":137.07,"eps":0,"divideRate":0.028518,"volume":845157,"delay":0,"ttmEps":0,"open":136.03,"prevYearClose":121.61,"prevWeekClose":132.19,"prevMonthClose":132.19,"prevQuarterClose":121.61,"fiveDayClose":132.19,"twentyDayClose":122.74,"sixtyDayClose":119.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HDV\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"HDV","amount":1.25288,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"HDV","amount":0.949579,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-06-16","symbol":"HDV","amount":0.91309,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2025-03-18","symbol":"HDV","amount":0.795075,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"},{"date":"2024-12-17","symbol":"HDV","amount":1.12172,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HDV\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-23","recordDate":"2016-03-28","paymentDate":"2016-03-30","value":0.676805,"currency":"USD"},{"executeDate":"2016-06-21","recordDate":"2016-06-23","paymentDate":"2016-06-27","value":0.679421,"currency":"USD"},{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.687623,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.655685,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.7228843,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HDV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HDV\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606209062","title":"Libevitug Approved in China as First-in-Class Hepatitis D Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2606209062","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606209062?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:15","pubTimestamp":1769501700,"startTime":"0","endTime":"0","summary":"BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China's National Medical Products Administration  has granted conditional approval to its Libevitug injection for chronic hepatitis D virus  infection in adults with or without compensated cirrhosis. Libevitug is a human monoclonal antibody targeting the PreS1 domain of hepatitis B virus  and HDV envelope proteins, blocking viral entry into hepatocytes. As a groundbreaking advance in viral hepatitis care, it is China's first approved HDV therapy and a first-in-class antibody for viral hepatitis, addressing a critical clinical gap.According to the World Health Organization , HDV affects nearly 5%  of people with chronic HBV infection. HDV–HBV co-infection is considered the most severe form of chronic viral hepatitis due to more rapid progression towards hepatocellular carcinoma and liver-related death.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2870372/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2870372/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/libevitug-approved-in-china-as-first-in-class-hepatitis-d-treatment-302670977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4588","BK4599","BK4139","LU1878469433.USD","BK4585","HDV"],"gpt_icon":0},{"id":"2603635736","title":"Vir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603635736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603635736?lang=en_us&edition=fundamental","pubTime":"2026-01-13 23:46","pubTimestamp":1768319170,"startTime":"0","endTime":"0","summary":"Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Vir Biotechnology. The associated price target remains the same wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vir-biotechnology-strengthening-best-in-class-hdv-profile-with-robust-solstice-data-strategic-partnerships-and-sufficient-cash-runway-supporting-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vir-biotechnology-strengthening-best-in-class-hdv-profile-with-robust-solstice-data-strategic-partnerships-and-sufficient-cash-runway-supporting-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HDV"],"gpt_icon":0},{"id":"2581388662","title":"Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®","url":"https://stock-news.laohu8.com/highlight/detail?id=2581388662","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581388662?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520400,"startTime":"0","endTime":"0","summary":"– Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – SOUTH SAN FRANCISCO, Calif., Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183614/16259/en/Assembly-Biosciences-Presents-Positive-Phase-1b-Data-for-Next-Generation-Capsid-Assembly-Modulator-ABI-4334-at-AASLD-The-Liver-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAM","ABI","ASMB","BK4585","HDV","BK4588","BK4139"],"gpt_icon":0},{"id":"2581589057","title":"Vir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581589057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581589057?lang=en_us&edition=fundamental","pubTime":"2025-11-06 17:05","pubTimestamp":1762419947,"startTime":"0","endTime":"0","summary":"Needham analyst Joseph Stringer has maintained their bullish stance on VIR stock, giving a Buy rating yesterday. Joseph Stringer has given his Buy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vir-biotechnologys-strategic-advancements-in-hdv-and-oncology-programs-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vir-biotechnologys-strategic-advancements-in-hdv-and-oncology-programs-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HDV"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HDV\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.018131},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.018143}]}}